scholarly journals Role and cost effectiveness of bariatric surgery in T2DM

2013 ◽  
Vol 14 (1) ◽  
pp. 17-19
Author(s):  
Jon Pinkney
Keyword(s):  
Bariatric Surgery ◽  
Cost Effectiveness

scholarly journals Incremental Net Monetary Benefit of Bariatric Surgery: Systematic Review and Meta-Analysis of Cost-Effectiveness Evidences

2021 ◽  
Author(s):  
Prapaporn Noparatayaporn ◽  
Montarat Thavorncharoensap ◽  
Usa Chaikledkaew ◽  
Bhavani Shankara Bagepally ◽  
Ammarin Thakkinstian
Keyword(s):  
Systematic Review ◽  
Bariatric Surgery ◽  
Cost Effectiveness ◽  
Evaluation Studies ◽  
Meta Analysis ◽  
Cost Effective ◽  
Diabetes Group ◽  
Lifetime Horizon ◽  
Middle Income ◽  
Full Economic Evaluation

AbstractThis systematic review aimed to comprehensively synthesize cost-effectiveness evidences of bariatric surgery by pooling incremental net monetary benefits (INB). Twenty-eight full economic evaluation studies comparing bariatric surgery with usual care were identified from five databases. In high-income countries (HICs), bariatric surgery was cost-effective among mixed obesity group (i.e., obesity with/without diabetes) over a 10-year time horizon (pooled INB = $53,063.69; 95% CI $42,647.96, $63,479.43) and lifetime horizon (pooled INB = $101,897.96; 95% CI $79,390.93, $124,404.99). All studies conducted among obese with diabetes reported that bariatric surgery was cost-effective. Also, the pooled INB for obesity with diabetes group over lifetime horizon in HICs was $80,826.28 (95% CI $32,500.75, $129,151.81). Nevertheless, no evidence is available in low- and middle-income countries. Graphical abstract

scholarly journals Cost-Effectiveness of Bariatric Surgery versus Medication Therapy for Obese Patients with Type 2 Diabetes in China: A Markov Analysis

2019 ◽  
Vol 2019 ◽  
pp. 1-11 ◽  
Author(s):  
Bin Wan ◽  
Nan Fang ◽  
Wei Guan ◽  
Haixia Ding ◽  
Ying Wang ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Bariatric Surgery ◽  
Health Care ◽  
Health Insurance ◽  
Cost Effectiveness ◽  
Time Horizon ◽  
Obese Patients ◽  
Medication Therapy ◽  
Insurance Payer

Aims/Introduction. The present study estimated the cost-effectiveness of bariatric surgery versus medication therapy for the management of recently diagnosed type 2 diabetes mellitus (T2DM) in obese patients from a Chinese health insurance payer perspective. Materials and Methods. A Markov model was established to compare the 40-year time costs and quality-adjusted life-years (QALYs) between bariatric surgery and medication therapy. The health-care costs in the bariatric surgery group, proportion of patients in each group with remission of diabetes, and state transition probabilities were calculated based on observed resource utilization from the hospital information system (HIS). The corresponding costs in the medication therapy group were derived from the medical insurance database. QALYs were estimated from previous literature. Costs and outcomes were discounted 5% annually. Results. In the base case analysis, bariatric surgery was more effective and less costly than medication therapy. Over a 40-year time horizon, the mean discounted costs were 86,366.55 RMB per surgical therapy patient and 113,235.94 CNY per medication therapy patient. The surgical and medication therapy patients lived 13.46 and 10.95 discounted QALYs, respectively. Bariatric surgery was associated with a mean health-care savings of 26,869.39 CNY and 2.51 additional QALYs per patient compared to medication therapy. Uncertainty around the parameter values was tested comprehensively in sensitivity analyses, and the results were robust. Conclusions. Bariatric surgery is a dominant intervention over a 40-year time horizon, which leads to significant cost savings to the health insurance payer and increases in health benefits for the management of recently diagnosed T2DM in obese patients in China.

Cost-effectiveness of an educational healthcare circuit for bariatric surgery in France

Public Health ◽  
2019 ◽  
Vol 172 ◽  
pp. 43-51
Author(s):  
A. Duenas ◽  
C. Di Martinelly ◽  
A. Aelbrecht ◽  
P.-E. Allard ◽  
J. Rousseaux
Keyword(s):  
Bariatric Surgery ◽  
Cost Effectiveness

scholarly journals Cost-Effectiveness Evaluation of Bariatric Surgery for Morbidly Obese with Diabetes Patients in Thailand

2019 ◽  
Vol 2019 ◽  
pp. 1-6 ◽  
Author(s):  
Ithiphon Viratanapanu ◽  
Chavalit Romyen ◽  
Komol Chaivanijchaya ◽  
Sikarin Sornphiphatphong ◽  
Worawit Kattipatanapong ◽  
...  
Keyword(s):  
Bariatric Surgery ◽  
Cost Effectiveness ◽  
Incremental Cost ◽  
Cost Effective ◽  
Diabetes Control ◽  
Effectiveness Evaluation ◽  
Morbidly Obese ◽  
The Cost ◽  
Dm Type 2

Background. Bariatric surgery is a choice for treatment in morbidly obese patients with type 2 diabetes mellitus (DM type 2) who have inadequate diabetes control with only medical treatment. However, bariatric surgery requires highly sophisticated equipment, and thus the cost of surgery seems to be very high following the procedure compared with the cost of conventional diabetes care. This raises the question of whether bariatric surgery is cost-effective for morbidly obese people with diabetes in Thailand. Objective. To perform a cost-effectiveness evaluation of bariatric surgery compared with ordinary treatment for diabetes control in morbidly obese DM type 2 patients in Thailand. Methods. Cost-effectiveness study was conducted, using a combination of decision tree and Markov model in analysis. Treatment outcomes and healthcare costs were incurred by data from literature review and retrospective cohort in King Chulalongkorn Memorial Hospital from September 2009 to March 2016 for the conventional and bariatric surgery group, respectively. One-way sensitivity was used for analysis of the robustness of the model. Cost-effectiveness was assessed by calculating incremental cost-effectiveness ratios (ICERs). Monetary benefits at a threshold of 150,000 to 200,000 Thai baht (THB) per quality-adjusted life-year (QALY) based on the Thailand gross domestic products (GDP) value was regarded as cost-effectiveness of bariatric surgery. Results. Bariatric surgery significantly improves the clinical outcome including long-term diabetes remission rate, hemoglobin A1C, and body mass index (BMI). The incremental cost per QALY of bariatric surgery compared with the medication control is 26,907.76 THB/QALY which can consider bariatric surgery as a cost-effective option. Conclusions. Use of bariatric surgery in morbidly obese with DM type 2 patients is a cost-effective strategy in Thailand’s context.

scholarly journals Cost-effectiveness of bariatric surgery in adolescents with severe obesity in the UK

2017 ◽  
Vol 8 (2) ◽  
pp. 105-113 ◽  
Author(s):  
M. Panca ◽  
R. M. Viner ◽  
B. White ◽  
T. Pandya ◽  
H. Melo ◽  
...  
Keyword(s):  
Bariatric Surgery ◽  
Cost Effectiveness ◽  
Severe Obesity ◽  
The Uk

scholarly journals Cost-Effectiveness of Bariatric Surgery for Severely Obese Adults With Diabetes

Diabetes Care ◽  
2010 ◽  
Vol 33 (9) ◽  
pp. 1933-1939 ◽  
Author(s):  
T. J. Hoerger ◽  
P. Zhang ◽  
J. E. Segel ◽  
H. S. Kahn ◽  
L. E. Barker ◽  
...  
Keyword(s):  
Bariatric Surgery ◽  
Cost Effectiveness ◽  
Obese Adults ◽  
Severely Obese

scholarly journals Cost-effectiveness of Bariatric Surgery

JAMA ◽  
2013 ◽  
Vol 310 (7) ◽  
pp. 742 ◽  
Author(s):  
Matthew L. Maciejewski ◽  
David E. Arterburn
Keyword(s):  
Bariatric Surgery ◽  
Cost Effectiveness

Adipositas-Chirurgie – Ist bariatrische Chirurgie kosteneffektiv?

2017 ◽  
Vol 22 (04) ◽  
pp. 182-183
Author(s):  
Cornelia Blaich
Keyword(s):  
Bariatric Surgery ◽  
Cohort Study ◽  
Cost Effectiveness ◽  
Electronic Health Records ◽  
Bariatrische Chirurgie ◽  
Cost Effectiveness Analysis ◽  
Health Records ◽  
Typ 2 Diabetes ◽  
Effectiveness Analysis ◽  
Electronic Health

Gulliford MC et al. Costs and Outcomes of Increasing Access to Bariatric Surgery: Cohort Study and Cost-Effectiveness Analysis Using Electronic Health Records. Value Health 2017; 20: 85–92 Ziele der bariatrischen Chirurgie bei Patienten mit morbider Adipositas sind neben der Gewichtsreduktion die Remission oder geringere Inzidenz eines Typ-2-Diabetes und eine Reduktion der Sterblichkeit. Die Autoren untersuchen in einer Kohortenstudie die Auswirkungen und Kosteneffektivität der bariatrischen Chirurgie im Vergleich zu einer nicht chirurgischen Behandlung der Adipositas.

Sign in / Sign up

Export Citation Format

Share Document